NCT02319837 2025-07-08Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)PfizerPhase 3 Active not recruiting1,068 enrolled 20 charts 1 FDA
NCT00544830 2025-05-07Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate CancerCity of Hope Medical CenterPhase 2 Active not recruiting29 enrolled 12 charts